{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:41:09Z","timestamp":1790372469276,"version":"4.1.0"},"reference-count":218,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>The high prevalence of cholesterol gallstones, the availability of new information about pathogenesis, and the relevant health costs due to the management of cholelithiasis in both children and adults contribute to a growing interest in this disease. From an epidemiologic point of view, the risk of gallstones has been associated with higher risk of incident ischemic heart disease, total mortality, and disease-specific mortality (including cancer) independently from the presence of traditional risk factors such as body weight, lifestyle, diabetes, and dyslipidemia. This evidence points to the existence of complex pathogenic pathways linking the occurrence of gallstones to altered systemic homeostasis involving multiple organs and dynamics. In fact, the formation of gallstones is secondary to local factors strictly dependent on the gallbladder (that is, impaired smooth muscle function, wall inflammation, and intraluminal mucin accumulation) and bile (that is, supersaturation in cholesterol and precipitation of solid crystals) but also to \u201cextra-gallbladder\u201d features such as gene polymorphism, epigenetic factors, expression and activity of nuclear receptors, hormonal factors (in particular, insulin resistance), multi-level alterations in cholesterol metabolism, altered intestinal motility, and variations in gut microbiota. Of note, the majority of these factors are potentially manageable. Thus, cholelithiasis appears as the expression of systemic unbalances that, besides the classic therapeutic approaches to patients with clinical evidence of symptomatic disease or complications (surgery and, in a small subgroup of subjects, oral litholysis with bile acids), could be managed with tools oriented to primary prevention (changes in diet and lifestyle and pharmacologic prevention in subgroups at high risk), and there could be relevant implications in reducing both prevalence and health costs.<\/ns4:p>","DOI":"10.12688\/f1000research.15505.1","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T04:30:06Z","timestamp":1537763406000},"page":"1529","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["Recent advances in understanding and managing cholesterol gallstones"],"prefix":"10.12688","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-7376","authenticated-orcid":false,"given":"Agostino","family":"Di Ciaula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-1471","authenticated-orcid":false,"given":"Piero","family":"Portincasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"1134-44","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas.","volume":"136","author":"J Everhart","year":"2009","journal-title":"Gastroenterology."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"539-43","DOI":"10.1177\/2050640614554154","article-title":"Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe.","volume":"2","author":"M Farthing","year":"2014","journal-title":"United European Gastroenterol J."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"1500-11","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States.","volume":"122","author":"R Sandler","year":"2002","journal-title":"Gastroenterology."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"132-40","DOI":"10.1007\/s11894-005-0051-8","article-title":"Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?","volume":"7","author":"E Shaffer","year":"2005","journal-title":"Curr Gastroenterol Rep."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"551-7","DOI":"10.1001\/jamasurg.2017.5461","article-title":"Factors Associated With Outcomes and Costs After Pediatric Laparoscopic Cholecystectomy.","volume":"153","author":"G Akhtar-Danesh","year":"2018","journal-title":"JAMA Surg."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"117-23","DOI":"10.14740\/jocmr2847w","article-title":"Symptomatic Gallstones in the Young: Changing Trends of the Gallstone Disease-Related Hospitalization in the State of New York: 1996 - 2010.","volume":"9","author":"S Chilimuri","year":"2017","journal-title":"J Clin Med Res."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"284-8; discussion 288","DOI":"10.1016\/j.jpedsurg.2013.11.053","article-title":"Cholecystectomy in English children: evidence of an epidemic (1997-2012).","volume":"49","author":"A Khoo","year":"2014","journal-title":"J Pediatr Surg."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"748-52","DOI":"10.1016\/j.jpedsurg.2016.02.017","article-title":"The increasing incidence of gallbladder disease in children: A 20year perspective.","volume":"51","author":"P Murphy","year":"2016","journal-title":"J Pediatr Surg."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"927-31; discussion 931","DOI":"10.1016\/j.surg.2013.04.040","article-title":"Etiology and incidence of pediatric gallbladder disease.","volume":"154","author":"S Walker","year":"2013","journal-title":"Surgery."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"328-33","DOI":"10.1097\/MPG.0b013e31824d256f","article-title":"Pediatric obesity and gallstone disease.","volume":"55","author":"C Koebnick","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"102-6","DOI":"10.1097\/MPG.0b013e3182a939cf","article-title":"Obesity and symptomatic cholelithiasis in childhood: epidemiologic and case-control evidence for a strong relation.","volume":"58","author":"K Fradin","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"e82-8","DOI":"10.1542\/peds.2011-0579","article-title":"Clinical characteristics and risk factors for symptomatic pediatric gallbladder disease.","volume":"129","author":"S Mehta","year":"2012","journal-title":"Pediatrics."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"66-70","DOI":"10.1097\/01.mpg.0000187816.31213.06","article-title":"Prevalence of gallbladder stone disease in obese children and adolescents: influence of the degree of obesity, sex, and pubertal development.","volume":"42","author":"V Kaechele","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"255-65","DOI":"10.1053\/j.sempedsurg.2012.05.008","article-title":"Gallstone disease in children.","volume":"21","author":"J Svensson","year":"2012","journal-title":"Semin Pediatr Surg."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"115-20","DOI":"10.5223\/pghn.2015.18.2.115","article-title":"Pediatric Cholecystectomy: Clinical Significance of Cases Unrelated to Hematologic Disorders.","volume":"18","author":"H Kim","year":"2015","journal-title":"Pediatr Gastroenterol Hepatol Nutr."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"683-7","DOI":"10.1055\/s-0028-1109957","article-title":"Gallstone prevalence and risk factors for gallstone disease in an urban population of children and adolescents.","volume":"48","author":"W Kratzer","year":"2010","journal-title":"Z Gastroenterol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"71-80","DOI":"10.1097\/MOG.0000000000000423","article-title":"An update on the pathogenesis of cholesterol gallstone disease.","volume":"34","author":"A Di Ciaula","year":"2018","journal-title":"Curr Opin Gastroenterol."},{"key":"ref-18","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14265","article-title":"Association of circulating inflammation proteins and gallstone disease.","author":"Z Liu","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"2232-7","DOI":"10.1161\/ATVBAHA.115.306043","article-title":"Gallstone Disease and the Risk of Ischemic Heart Disease.","volume":"35","author":"J Lv","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"1997-2003","DOI":"10.1161\/ATVBAHA.116.307507","article-title":"Gallstones and Risk of Coronary Heart Disease: Prospective Analysis of 270\u2009000 Men and Women From 3 US Cohorts and Meta-Analysis.","volume":"36","author":"Y Zheng","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"ref-21","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14264","article-title":"Gallstone disease and increased risk of mortality: Two large prospective studies in US men and women.","author":"Y Zheng","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"353-60","DOI":"10.1007\/s00038-016-0916-7","article-title":"Gallstone disease and mortality: a cohort study.","volume":"62","author":"D Shabanzadeh","year":"2017","journal-title":"Int J Public Health."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"778-82","DOI":"10.1038\/nm1785","article-title":"Hepatic insulin resistance directly promotes formation of cholesterol gallstones.","volume":"14","author":"S Biddinger","year":"2008","journal-title":"Nat Med."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"299-303","DOI":"10.1002\/hep.510310206","article-title":"Association of diabetes, serum insulin, and C-peptide with gallbladder disease.","volume":"31","author":"C Ruhl","year":"2000","journal-title":"Hepatology."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"521-5","DOI":"10.1136\/bmj.289.6444.521","article-title":"Plasma lipids and insulin in gall stone disease: a case-control study.","volume":"289","author":"R Scragg","year":"1984","journal-title":"Br Med J (Clin Res Ed)."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"144-7","DOI":"10.1136\/gut.47.1.144","article-title":"Insulin and gall stones: a population case control study in southern Italy.","volume":"47","author":"G Misciagna","year":"2000","journal-title":"Gut."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"644-50","DOI":"10.3346\/jkms.2008.23.4.644","article-title":"Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men.","volume":"23","author":"Y Chang","year":"2008","journal-title":"J Korean Med Sci."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1471-2296-15-138","article-title":"The association of metabolic syndrome and its factors with gallstone disease.","volume":"15","author":"I Lin","year":"2014","journal-title":"BMC Fam Pract."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"1424-9","DOI":"10.1038\/bjc.2011.363","article-title":"Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China.","volume":"105","author":"F Shebl","year":"2011","journal-title":"Br J Cancer."},{"key":"ref-30","first-page":"357-372","article-title":"Role of insulin resistance in the formation of cholesterol gallstones.","author":"A Di Ciaula","year":"2016"},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"15853","DOI":"10.1038\/s41598-017-14801-2","article-title":"Gallstone Disease and the Risk of Type 2 Diabetes.","volume":"7","author":"J Lv","year":"2017","journal-title":"Sci Rep."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"e7853","DOI":"10.1097\/MD.0000000000007853","article-title":"Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population.","volume":"96","author":"Q Qiao","year":"2017","journal-title":"Medicine (Baltimore)."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"731-9","DOI":"10.1093\/aje\/kwt322","article-title":"Gallstones, cholecystectomy, and risk of digestive system cancers.","volume":"179","author":"L Nogueira","year":"2014","journal-title":"Am J Epidemiol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"1467-74","DOI":"10.3109\/00365521.2012.719928","article-title":"Increased cancer incidence in some gallstone diseases, and equivocal effect of cholecystectomy: A long-term analysis of cancer and mortality.","volume":"47","author":"M Schmidt","year":"2012","journal-title":"Scand J Gastroenterol."},{"key":"ref-35","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000421","article-title":"Gallstones and cholecystectomy in relation to risk of liver cancer.","author":"Y Wang","year":"2018","journal-title":"Eur J Cancer Prev."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"131-7","DOI":"10.14701\/ahbps.2017.21.3.131","article-title":"Gallstone, cholecystectomy and risk of gastric cancer.","volume":"21","author":"S Kang","year":"2017","journal-title":"Ann Hepatobiliary Pancreat Surg."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"1965-1974.e1","DOI":"10.1053\/j.gastro.2017.02.013","article-title":"Association Between Screen-Detected Gallstone Disease and Cancer in a Cohort Study.","volume":"152","author":"D Shabanzadeh","year":"2017","journal-title":"Gastroenterology."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"1-2","DOI":"10.1093\/ajcn\/80.1.1","article-title":"Cholesterol gallstones: a fellow traveler with metabolic syndrome?","volume":"80","author":"S Grundy","year":"2004","journal-title":"Am J Clin Nutr."},{"key":"ref-39","first-page":"335-353","article-title":"Gallstones.","author":"P Portincasa","year":"2016"},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"93-112","DOI":"10.1586\/17474124.2016.1109445","article-title":"Management of gallstones and its related complications.","volume":"10","author":"P Portincasa","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"138-41","DOI":"10.1002\/hep.1840220122","article-title":"High familial prevalence of gallstones in the first-degree relatives of gallstone patients.","volume":"22","author":"S Sarin","year":"1995","journal-title":"Hepatology."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"832-8","DOI":"10.1002\/ijc.22756","article-title":"Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China.","volume":"121","author":"A Hsing","year":"2007","journal-title":"Int J Cancer."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"618-30","DOI":"10.1001\/archinte.1972.03650040142013","article-title":"Bile composition, bile salt metabolism and gallstones.","volume":"130","author":"R Redinger","year":"1972","journal-title":"Arch Intern Med."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"230-9","DOI":"10.1016\/S0140-6736(06)69044-2","article-title":"Cholesterol gallstone disease.","volume":"368","author":"P Portincasa","year":"2006","journal-title":"Lancet."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"995-9","DOI":"10.1038\/ng2101","article-title":"A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease.","volume":"39","author":"S Buch","year":"2007","journal-title":"Nat Genet."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2350-14-120","article-title":"Lipid trait-associated genetic variation is associated with gallstone disease in the diverse Third National Health and Nutrition Examination Survey (NHANES III).","volume":"14","author":"R Goodloe","year":"2013","journal-title":"BMC Med Genet."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"351-363.e28","DOI":"10.1053\/j.gastro.2016.04.007","article-title":"Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies.","volume":"151","author":"A Joshi","year":"2016","journal-title":"Gastroenterology."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"793-801","DOI":"10.1002\/hep.21847","article-title":"Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol.","volume":"46","author":"F Gr\u00fcnhage","year":"2007","journal-title":"Hepatology."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"80-5","DOI":"10.1016\/j.cca.2007.06.004","article-title":"ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males.","volume":"384","author":"Y Wang","year":"2007","journal-title":"Clin Chim Acta."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"464-72","DOI":"10.1194\/jlr.M700295-JLR200","article-title":"Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients.","volume":"49","author":"Z Jiang","year":"2008","journal-title":"J Lipid Res."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"1005-11","DOI":"10.1002\/bjs.6178","article-title":"Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease.","volume":"95","author":"K Kuo","year":"2008","journal-title":"Br J Surg."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"343-8","DOI":"10.1111\/j.1753-4887.2008.00042.x","article-title":"Polymorphisms in ABCG5\/G8 transporters linked to hypercholesterolemia and gallstone disease.","volume":"66","author":"I Rudkowska","year":"2008","journal-title":"Nutr Rev."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"279-85","DOI":"10.1111\/j.1365-2796.2010.02249.x","article-title":"Gallstone disease in Swedish twins: Risk is associated with ABCG8 D19H genotype.","volume":"268","author":"D Katsika","year":"2010","journal-title":"J Intern Med."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"2407-17","DOI":"10.1002\/hep.26009","article-title":"Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5\/8 lithogenic locus.","volume":"57","author":"O von Kampen","year":"2013","journal-title":"Hepatology."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"391-6","DOI":"10.1007\/s00535-012-0639-3","article-title":"Recurrence of gallstones after cholecystectomy is associated with ABCG5\/8 genotype.","volume":"48","author":"W von Sch\u00f6nfels","year":"2013","journal-title":"J Gastroenterol."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"58-62","DOI":"10.1093\/carcin\/bgq194","article-title":"Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: A population-based case-control study in Shanghai, China.","volume":"32","author":"H Xu","year":"2011","journal-title":"Carcinogenesis."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"68-79","DOI":"10.1016\/j.clinre.2014.07.002","article-title":"Association of FXR gene variants with cholelithiasis.","volume":"39","author":"S Hirobe-Jahn","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"ref-58","doi-asserted-by":"crossref","first-page":"515-23","DOI":"10.1016\/S1665-2681(19)31173-1","article-title":"Influence of ApoE and FABP2 polymorphisms and environmental factors in the susceptibility to gallstone disease.","volume":"14","author":"E Martinez-Lopez","year":"2015","journal-title":"Ann Hepatol."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"1466-71","DOI":"10.1016\/j.cca.2012.06.015","article-title":"Mucin genes in gallstone disease.","volume":"413","author":"S Chuang","year":"2012","journal-title":"Clin Chim Acta."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"548-55","DOI":"10.4238\/2012.March.8.3","article-title":"Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population.","volume":"11","author":"Q Chen","year":"2012","journal-title":"Genet Mol Res."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"2089-93","DOI":"10.1016\/j.cca.2011.07.015","article-title":"Polymorphism at the mucin-like protocadherin gene influences susceptibility to gallstone disease.","volume":"412","author":"S Chuang","year":"2011","journal-title":"Clin Chim Acta."},{"key":"ref-62","doi-asserted-by":"crossref","first-page":"842-9","DOI":"10.1097\/00000658-200206000-00012","article-title":"Gallstones: Genetics versus environment.","volume":"235","author":"A Nakeeb","year":"2002","journal-title":"Ann Surg."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"1138-43","DOI":"10.1002\/hep.20654","article-title":"Genetic and environmental influences on symptomatic gallstone disease: A Swedish study of 43,141 twin pairs.","volume":"41","author":"D Katsika","year":"2005","journal-title":"Hepatology."},{"key":"ref-64","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170530080636","article-title":"The Role Of Diet In The Pathogenesis Of Cholesterol Gallstones.","author":"A Di Ciaula","year":"2017","journal-title":"Curr Med Chem."},{"key":"ref-65","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170518095736","article-title":"Diet and contaminants: Driving the rise to obesity epidemics?","author":"A Di Ciaula","year":"2017","journal-title":"Curr Med Chem."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"191-201","DOI":"10.1159\/000323885","article-title":"Gallstones: Environment, lifestyle and genes.","volume":"29","author":"C Stokes","year":"2011","journal-title":"Dig Dis."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"117-25","DOI":"10.1111\/j.1477-2574.2010.00255.x","article-title":"Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India.","volume":"13","author":"S Unisa","year":"2011","journal-title":"HPB (Oxford)."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"433-43","DOI":"10.1016\/j.scitotenv.2016.08.110","article-title":"Combined microstructural and mineralogical phase characterization of gallstones in a patient-based study in SW Spain - Implications for environmental contamination in their formation.","volume":"573","author":"A Parviainen","year":"2016","journal-title":"Sci Total Environ."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"592-7","DOI":"10.1016\/j.annepidem.2012.05.002","article-title":"Serum organochlorine pesticide residues and risk of gallstone disease: A case-control study in Xiamen.","volume":"22","author":"Y Su","year":"2012","journal-title":"Ann Epidemiol."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"33689-702","DOI":"10.18632\/oncotarget.9399","article-title":"Organochloride pesticides induced hepatic ABCG5\/G8 expression and lipogenesis in Chinese patients with gallstone disease.","volume":"7","author":"G Ji","year":"2016","journal-title":"Oncotarget."},{"key":"ref-71","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/298421","article-title":"Current views on genetics and epigenetics of cholesterol gallstone disease.","volume":"2013","author":"A Di Ciaula","year":"2013","journal-title":"Cholesterol."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"1103-13","DOI":"10.1194\/jlr.R084244","article-title":"ABCG5 and ABCG8: More than a defense against xenosterols.","volume":"59","author":"S Patel","year":"2018","journal-title":"J Lipid Res."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"961-75","DOI":"10.4254\/wjh.v8.i23.961","article-title":"Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training.","volume":"8","author":"J Lavoie","year":"2016","journal-title":"World J Hepatol."},{"key":"ref-74","doi-asserted-by":"publisher","first-page":"e6556","DOI":"10.1097\/MD.0000000000006556","article-title":"Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis.","volume":"96","author":"S Wang","year":"2017","journal-title":"Medicine (Baltimore)."},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"1828-37","DOI":"10.1002\/hep.25861","article-title":"Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5\/G8 complex.","volume":"56","author":"Y Bonde","year":"2012","journal-title":"Hepatology."},{"key":"ref-76","doi-asserted-by":"crossref","first-page":"487-93","DOI":"10.1016\/S1665-2681(19)31170-6","article-title":"The nuclear receptor FXR, but not LXR, up-regulates bile acid transporter expression in non-alcoholic fatty liver disease.","volume":"14","author":"N Aguilar-Olivos","year":"2015","journal-title":"Ann Hepatol."},{"key":"ref-77","doi-asserted-by":"publisher","first-page":"e005","DOI":"10.1621\/nrs.08005","article-title":"Deciphering the nuclear bile acid receptor FXR paradigm.","volume":"8","author":"S Modica","year":"2010","journal-title":"Nucl Recept Signal."},{"key":"ref-78","doi-asserted-by":"publisher","first-page":"1331-42","DOI":"10.1002\/hep.22175","article-title":"Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.","volume":"47","author":"H Uppal","year":"2008","journal-title":"Hepatology."},{"key":"ref-79","doi-asserted-by":"publisher","first-page":"413-26","DOI":"10.1111\/eci.12058","article-title":"Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.","volume":"43","author":"H Wang","year":"2013","journal-title":"Eur J Clin Invest."},{"key":"ref-80","doi-asserted-by":"publisher","first-page":"935-47","DOI":"10.1111\/j.1478-3231.2008.01808.x","article-title":"Ezetimibe prevents cholesterol gallstone formation in mice.","volume":"28","author":"S Z\u00fa\u00f1iga","year":"2008","journal-title":"Liver Int."},{"key":"ref-81","doi-asserted-by":"publisher","first-page":"2101-10","DOI":"10.1053\/j.gastro.2008.03.011","article-title":"Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.","volume":"134","author":"H Wang","year":"2008","journal-title":"Gastroenterology."},{"key":"ref-82","doi-asserted-by":"publisher","first-page":"1691-700","DOI":"10.1194\/jlr.M059121","article-title":"Estrogen induces two distinct cholesterol crystallization pathways by activating ER\u03b1 and GPR30 in female mice.","volume":"56","author":"O de Bari","year":"2015","journal-title":"J Lipid Res."},{"key":"ref-83","doi-asserted-by":"publisher","first-page":"1037-47","DOI":"10.1016\/j.bbalip.2009.06.006","article-title":"New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation.","volume":"1791","author":"H Wang","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"ref-84","doi-asserted-by":"publisher","first-page":"157-69, vii","DOI":"10.1016\/j.gtc.2010.02.003","article-title":"Epidemiology of gallstones.","volume":"39","author":"L Stinton","year":"2010","journal-title":"Gastroenterol Clin North Am."},{"key":"ref-85","doi-asserted-by":"publisher","first-page":"641-731","DOI":"10.1016\/0011-5029(90)90015-J","article-title":"Metabolic and health complications of obesity.","volume":"36","author":"S Grundy","year":"1990","journal-title":"Dis Mon."},{"key":"ref-86","doi-asserted-by":"publisher","first-page":"2243-4","DOI":"10.1161\/01.ATV.0000189155.75833.c7","article-title":"Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute.","volume":"25","author":"S Grundy","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"ref-87","doi-asserted-by":"publisher","first-page":"2735-52","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement.","volume":"112","author":"S Grundy","year":"2005","journal-title":"Circulation."},{"key":"ref-88","doi-asserted-by":"publisher","first-page":"1415-28","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome.","volume":"365","author":"R Eckel","year":"2005","journal-title":"Lancet."},{"key":"ref-89","doi-asserted-by":"publisher","first-page":"38-44","DOI":"10.1093\/ajcn\/80.1.38","article-title":"Prospective study of abdominal adiposity and gallstone disease in US men.","volume":"80","author":"C Tsai","year":"2004","journal-title":"Am J Clin Nutr."},{"key":"ref-90","doi-asserted-by":"publisher","first-page":"3143-421","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.","volume":"106","year":"2002","journal-title":"Circulation."},{"key":"ref-91","doi-asserted-by":"publisher","first-page":"387-96","DOI":"10.1016\/0003-9861(74)90412-3","article-title":"Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone.","volume":"160","author":"C Nepokroeff","year":"1974","journal-title":"Arch Biochem Biophys."},{"key":"ref-92","doi-asserted-by":"publisher","first-page":"304292","DOI":"10.1155\/2012\/304292","article-title":"A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways.","volume":"2012","author":"G Garruti","year":"2012","journal-title":"J Lipids."},{"key":"ref-93","doi-asserted-by":"publisher","first-page":"s4-s14","DOI":"10.5604\/01.3001.0010.5493","article-title":"Bile Acid Physiology.","volume":"16","author":"A Di Ciaula","year":"2017","journal-title":"Ann Hepatol."},{"key":"ref-94","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones.","volume":"2","author":"F Lammert","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"ref-95","doi-asserted-by":"publisher","first-page":"1159-68","DOI":"10.1111\/eci.12350","article-title":"Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.","volume":"44","author":"O de Bari","year":"2014","journal-title":"Eur J Clin Invest."},{"key":"ref-96","doi-asserted-by":"publisher","first-page":"302847","DOI":"10.1155\/2012\/302847","article-title":"Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease.","volume":"2012","author":"O de Bari","year":"2012","journal-title":"J Lipids."},{"key":"ref-97","doi-asserted-by":"publisher","DOI":"10.4199\/C00147ED2V01Y201611ISP071","article-title":"The Biliary System. Second Edition","author":"D Wang","year":"2017"},{"key":"ref-98","doi-asserted-by":"publisher","first-page":"1615-26","DOI":"10.1172\/JCI94230","article-title":"FoxO transcription factors are required for hepatic HDL cholesterol clearance.","volume":"128","author":"S Lee","year":"2018","journal-title":"J Clin Invest."},{"key":"ref-99","doi-asserted-by":"publisher","first-page":"3986-93","DOI":"10.1016\/j.bmc.2016.06.039","article-title":"Novel FXR (farnesoid X receptor) modulators: Potential therapies for cholesterol gallstone disease.","volume":"24","author":"D Yu","year":"2016","journal-title":"Bioorg Med Chem."},{"key":"ref-100","doi-asserted-by":"publisher","first-page":"112-7","DOI":"10.1016\/j.ejphar.2015.01.038","article-title":"Piperine prevents cholesterol gallstones formation in mice.","volume":"751","author":"X Song","year":"2015","journal-title":"Eur J Pharmacol."},{"key":"ref-101","doi-asserted-by":"publisher","first-page":"221-48","DOI":"10.1146\/annurev.physiol.69.031905.160725","article-title":"Regulation of intestinal cholesterol absorption.","volume":"69","author":"D Wang","year":"2007","journal-title":"Annu Rev Physiol."},{"key":"ref-102","doi-asserted-by":"publisher","first-page":"578-81","DOI":"10.1172\/JCI113107","article-title":"Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.","volume":"80","author":"Y Kes\u00e4niemi","year":"1987","journal-title":"J Clin Invest."},{"key":"ref-103","doi-asserted-by":"crossref","first-page":"302-8","DOI":"10.1016\/S0022-2275(20)33370-8","article-title":"Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry.","volume":"40","author":"M Bosner","year":"1999","journal-title":"J Lipid Res."},{"key":"ref-104","first-page":"26-44","article-title":"Absorption and Excretion of Cholesterol and Other Sterols.","author":"D Wang","year":"2008"},{"key":"ref-105","doi-asserted-by":"publisher","first-page":"1435-47","DOI":"10.2174\/09298673113206660271","article-title":"Therapeutic reflections in cholesterol homeostasis and gallstone disease: A review.","volume":"21","author":"A Di Ciaula","year":"2014","journal-title":"Curr Med Chem."},{"key":"ref-106","doi-asserted-by":"publisher","first-page":"2121-8","DOI":"10.1016\/j.jacc.2013.12.055","article-title":"The ABCG5\/8 cholesterol transporter and myocardial infarction versus gallstone disease.","volume":"63","author":"S Stender","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"ref-107","doi-asserted-by":"publisher","first-page":"1507-17","DOI":"10.1002\/hep.25563","article-title":"Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone disease.","volume":"55","author":"M Krawczyk","year":"2012","journal-title":"Hepatology."},{"key":"ref-108","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-230X-13-30","article-title":"Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease.","volume":"13","author":"O Renner","year":"2013","journal-title":"BMC Gastroenterol."},{"key":"ref-109","doi-asserted-by":"publisher","first-page":"1182-8","DOI":"10.3945\/ajcn.110.006668","article-title":"Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity.","volume":"94","author":"P Paramsothy","year":"2011","journal-title":"Am J Clin Nutr."},{"key":"ref-110","doi-asserted-by":"publisher","first-page":"2422-7","DOI":"10.1194\/jlr.P006619","article-title":"Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: Lessons from the METSIM Study.","volume":"51","author":"H Gylling","year":"2010","journal-title":"J Lipid Res."},{"key":"ref-111","doi-asserted-by":"publisher","first-page":"1785-92","DOI":"10.3892\/mmr.2017.6774","article-title":"Osteopontin deficiency protects mice from cholesterol gallstone formation by reducing expression of intestinal NPC1L1.","volume":"16","author":"J Lin","year":"2017","journal-title":"Mol Med Rep."},{"key":"ref-112","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/1471-2164-14-669","article-title":"Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study.","volume":"14","author":"T Wu","year":"2013","journal-title":"BMC Genomics."},{"key":"ref-113","doi-asserted-by":"publisher","first-page":"630-5","DOI":"10.1136\/gut.2003.028431","article-title":"Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly.","volume":"54","author":"L Thomas","year":"2005","journal-title":"Gut."},{"key":"ref-114","doi-asserted-by":"publisher","first-page":"874-80","DOI":"10.1111\/1758-2229.12319","article-title":"Interactions between the intestinal microbiota and bile acids in gallstones patients.","volume":"7","author":"N Keren","year":"2015","journal-title":"Environ Microbiol Rep."},{"key":"ref-115","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12876-017-0629-2","article-title":"Alteration of gut microbiota in association with cholesterol gallstone formation in mice.","volume":"17","author":"Q Wang","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"ref-116","first-page":"1378-82","article-title":"Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index.","volume":"84","author":"G Palasciano","year":"1989","journal-title":"Am J Gastroenterol."},{"key":"ref-117","first-page":"493-7","article-title":"Gallbladder volume in adults, and relationship to age, sex, body mass index, and gallstones: a sonographic population study.","volume":"87","author":"G Palasciano","year":"1992","journal-title":"Am J Gastroenterol."},{"key":"ref-118","first-page":"323-327","article-title":"Ultrasonographic study of gallbladder and gastric dynamics in obese people after oral cholestyramine.","author":"P Portincasa","year":"1994"},{"key":"ref-119","doi-asserted-by":"publisher","first-page":"2112-26","DOI":"10.1002\/hep.22204","article-title":"Coordinate regulation of gallbladder motor function in the gut-liver axis.","volume":"47","author":"P Portincasa","year":"2008","journal-title":"Hepatology."},{"key":"ref-120","doi-asserted-by":"publisher","first-page":"151-62","DOI":"10.1007\/s11894-004-0043-0","article-title":"Smooth muscle function and dysfunction in gallbladder disease.","volume":"6","author":"P Portincasa","year":"2004","journal-title":"Curr Gastroenterol Rep."},{"key":"ref-121","doi-asserted-by":"publisher","first-page":"66-70","DOI":"10.1046\/j.1365-2036.2000.014s2066.x","article-title":"Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones.","volume":"14 Suppl 2","author":"K van Erpecum","year":"2000","journal-title":"Aliment Pharmacol Ther."},{"key":"ref-122","doi-asserted-by":"publisher","first-page":"e313-24","DOI":"10.1111\/j.1365-2982.2012.01935.x","article-title":"Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease.","volume":"24","author":"B Lavoie","year":"2012","journal-title":"Neurogastroenterol Motil."},{"key":"ref-123","doi-asserted-by":"publisher","first-page":"580-7","DOI":"10.1002\/hep.510240320","article-title":"Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy.","volume":"24","author":"P Portincasa","year":"1996","journal-title":"Hepatology."},{"key":"ref-124","doi-asserted-by":"publisher","first-page":"765-71","DOI":"10.1053\/gast.1996.v111.pm8780583","article-title":"Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence.","volume":"111","author":"J Pauletzki","year":"1996","journal-title":"Gastroenterology."},{"key":"ref-125","doi-asserted-by":"publisher","first-page":"430-40","DOI":"10.1016\/S0168-8278(05)80324-1","article-title":"Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation.","volume":"21","author":"P Portincasa","year":"1994","journal-title":"J Hepatol."},{"key":"ref-126","doi-asserted-by":"publisher","first-page":"353-9","DOI":"10.1007\/BF01536255","article-title":"Plasma cholecystokinin and gallbladder responses to intraduodenal fat in gallstone patients.","volume":"34","author":"A Masclee","year":"1989","journal-title":"Dig Dis Sci."},{"key":"ref-127","doi-asserted-by":"publisher","first-page":"1443-7","DOI":"10.1136\/gut.34.10.1443","article-title":"Correlation between gall bladder fasting volume and postprandial emptying in patients with gall stones and healthy controls.","volume":"34","author":"J Pauletzki","year":"1993","journal-title":"Gut."},{"key":"ref-128","doi-asserted-by":"publisher","first-page":"1882-8","DOI":"10.1016\/0016-5085(95)90153-1","article-title":"Gallbladder emptying in vivo, bile composition, and nucleation of cholesterol crystals in patients with cholesterol gallstones.","volume":"108","author":"M Stolk","year":"1995","journal-title":"Gastroenterology."},{"key":"ref-129","doi-asserted-by":"publisher","first-page":"194-202","DOI":"10.1016\/0168-8278(92)90158-L","article-title":"Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects.","volume":"14","author":"K van Erpecum","year":"1992","journal-title":"J Hepatol."},{"key":"ref-130","doi-asserted-by":"publisher","first-page":"787-91","DOI":"10.1016\/0016-5085(85)90152-0","article-title":"Abnormal gallbladder emptying in a subgroup of patients with gallstones.","volume":"88","author":"I Pomeranz","year":"1985","journal-title":"Gastroenterology."},{"key":"ref-131","doi-asserted-by":"publisher","first-page":"47-52","DOI":"10.1016\/0022-4804(86)90007-7","article-title":"The effects of prosthetic gallstones on gallbladder function and bile composition.","volume":"41","author":"I Pomeranz","year":"1986","journal-title":"J Surg Res."},{"key":"ref-132","doi-asserted-by":"publisher","first-page":"2576-81; quiz 2672","DOI":"10.1111\/j.1572-0241.2006.00793.x","article-title":"Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a clinical setting.","volume":"101","author":"A Colecchia","year":"2006","journal-title":"Am J Gastroenterol."},{"key":"ref-133","doi-asserted-by":"publisher","first-page":"184-91","DOI":"10.1016\/0002-9610(86)90030-9","article-title":"Gallbladder absorption increases during early cholesterol gallstone formation.","volume":"151","author":"R Conter","year":"1986","journal-title":"Am J Surg."},{"key":"ref-134","doi-asserted-by":"publisher","first-page":"75-80","DOI":"10.1097\/00000441-198608000-00002","article-title":"Enhanced gallbladder absorption during gallstone formation: the roles of cholesterol saturated bile and gallbladder stasis.","volume":"292","author":"J Roslyn","year":"1986","journal-title":"Am J Med Sci."},{"key":"ref-135","doi-asserted-by":"publisher","first-page":"912-20","DOI":"10.1016\/S0016-5085(00)70177-6","article-title":"Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile.","volume":"118","author":"S Corradini","year":"2000","journal-title":"Gastroenterology."},{"key":"ref-136","doi-asserted-by":"publisher","first-page":"G1017-26","DOI":"10.1152\/ajpgi.1999.277.5.G1017","article-title":"Cholesterol inhibits spontaneous action potentials and calcium currents in guinea pig gallbladder smooth muscle.","volume":"277","author":"L Jennings","year":"1999","journal-title":"Am J Physiol."},{"key":"ref-137","doi-asserted-by":"publisher","first-page":"1685-9","DOI":"10.3748\/wjg.v11.i11.1685","article-title":"Gallbladder motor function, plasma cholecystokinin and cholecystokinin receptor of gallbladder in cholesterol stone patients.","volume":"11","author":"J Zhu","year":"2005","journal-title":"World J Gastroenterol."},{"key":"ref-138","doi-asserted-by":"publisher","first-page":"G203-11","DOI":"10.1152\/ajpgi.1998.275.2.G203","article-title":"Signal transduction pathways mediating CCK-induced gallbladder muscle contraction.","volume":"275","author":"P Yu","year":"1998","journal-title":"Am J Physiol."},{"key":"ref-139","doi-asserted-by":"publisher","first-page":"G1401-7","DOI":"10.1152\/ajpgi.1999.276.6.G1401","article-title":"CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones.","volume":"276","author":"Z Xiao","year":"1999","journal-title":"Am J Physiol."},{"key":"ref-140","doi-asserted-by":"publisher","first-page":"G742-50","DOI":"10.1152\/ajpgi.00064.2010","article-title":"Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle.","volume":"299","author":"P Cong","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"ref-141","doi-asserted-by":"publisher","first-page":"763-70","DOI":"10.1016\/0016-5085(94)90713-7","article-title":"Cholecystokinin-coupled intracellular signaling in human gallbladder muscle.","volume":"106","author":"P Yu","year":"1994","journal-title":"Gastroenterology."},{"key":"ref-142","doi-asserted-by":"publisher","first-page":"G1082-9","DOI":"10.1152\/ajpgi.1993.265.6.G1082","article-title":"Interaction between signal transduction pathways contributing to gallbladder tonic contraction.","volume":"265","author":"P Yu","year":"1993","journal-title":"Am J Physiol."},{"key":"ref-143","doi-asserted-by":"publisher","first-page":"G659-65","DOI":"10.1152\/ajpgi.1995.269.5.G659","article-title":"Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones.","volume":"269","author":"P Yu","year":"1995","journal-title":"Am J Physiol."},{"key":"ref-144","doi-asserted-by":"publisher","first-page":"401-23","DOI":"10.2741\/2688","article-title":"Molecular pathophysiology and physical chemistry of cholesterol gallstones.","volume":"13","author":"H Wang","year":"2008","journal-title":"Front Biosci."},{"key":"ref-145","doi-asserted-by":"publisher","first-page":"792-5","DOI":"10.1016\/j.dld.2016.03.014","article-title":"The enteric nervous system in patients with calculous and acalculous gallbladder.","volume":"48","author":"V Villanacci","year":"2016","journal-title":"Dig Liver Dis."},{"key":"ref-146","doi-asserted-by":"publisher","first-page":"506-11","DOI":"10.1053\/gast.2001.21190","article-title":"Gallbladder muscle dysfunction in patients with chronic acalculous disease.","volume":"120","author":"J Amaral","year":"2001","journal-title":"Gastroenterology."},{"key":"ref-147","doi-asserted-by":"publisher","first-page":"930-7","DOI":"10.1016\/S0016-5085(97)70189-6","article-title":"Gallbladder relaxation in patients with pigment and cholesterol stones.","volume":"113","author":"Q Chen","year":"1997","journal-title":"Gastroenterology."},{"key":"ref-148","doi-asserted-by":"publisher","first-page":"102-6","DOI":"10.1007\/BF03326426","article-title":"Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism.","volume":"37 Suppl 14","author":"K Miyasaka","year":"2002","journal-title":"J Gastroenterol."},{"key":"ref-149","doi-asserted-by":"publisher","first-page":"940-8; discussion 948-9","DOI":"10.1016\/j.gassur.2006.04.005","article-title":"Insulin resistance causes human gallbladder dysmotility.","volume":"10","author":"A Nakeeb","year":"2006","journal-title":"J Gastrointest Surg."},{"key":"ref-150","doi-asserted-by":"publisher","first-page":"981-1030","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications.","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev."},{"key":"ref-151","doi-asserted-by":"publisher","first-page":"373-8","DOI":"10.1111\/j.1365-2265.2011.04210.x","article-title":"Impaired gallbladder motility and the effect of metformin therapy in patients with polycystic ovary syndrome.","volume":"76","author":"S Isik","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"key":"ref-152","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fphar.2017.00765","article-title":"Metformin Use Correlates with Reduced Risk of Gallstones in Diabetic Patients: A 12-Year Follow-up Study.","volume":"8","author":"K Liao","year":"2017","journal-title":"Front Pharmacol."},{"key":"ref-153","doi-asserted-by":"publisher","first-page":"1253-5","DOI":"10.1038\/nm1501","article-title":"Identification of a hormonal basis for gallbladder filling.","volume":"12","author":"M Choi","year":"2006","journal-title":"Nat Med."},{"key":"ref-154","doi-asserted-by":"crossref","first-page":"710-21","DOI":"10.1016\/S1665-2681(19)30766-5","article-title":"Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.","volume":"14","author":"F Barrera","year":"2015","journal-title":"Ann Hepatol."},{"key":"ref-155","doi-asserted-by":"publisher","first-page":"575-83","DOI":"10.1002\/hep.24702","article-title":"The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.","volume":"55","author":"S Zweers","year":"2012","journal-title":"Hepatology."},{"key":"ref-156","doi-asserted-by":"publisher","first-page":"1549-77","DOI":"10.1002\/cphy.c150050","article-title":"Functions of the Gallbladder.","volume":"6","author":"C Housset","year":"2016","journal-title":"Compr Physiol."},{"key":"ref-157","doi-asserted-by":"publisher","first-page":"714-9","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR).","volume":"298","author":"T Maruyama","year":"2002","journal-title":"Biochem Biophys Res Commun."},{"key":"ref-158","doi-asserted-by":"publisher","first-page":"861-70","DOI":"10.1002\/hep.23032","article-title":"The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders.","volume":"50","author":"V Keitel","year":"2009","journal-title":"Hepatology."},{"key":"ref-159","doi-asserted-by":"publisher","first-page":"1066-71","DOI":"10.1210\/me.2010-0460","article-title":"The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling.","volume":"25","author":"T Li","year":"2011","journal-title":"Mol Endocrinol."},{"key":"ref-160","doi-asserted-by":"publisher","first-page":"3295-305","DOI":"10.1113\/jphysiol.2010.192146","article-title":"Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels.","volume":"588","author":"B Lavoie","year":"2010","journal-title":"J Physiol."},{"key":"ref-161","doi-asserted-by":"publisher","first-page":"830-5","DOI":"10.1136\/gut.42.6.830","article-title":"Motilin induces gall bladder emptying and antral contractions in the fasted state in humans.","volume":"42","author":"Y Luiking","year":"1998","journal-title":"Gut."},{"key":"ref-162","doi-asserted-by":"publisher","first-page":"421-30","DOI":"10.1046\/j.1365-2982.2000.00217.x","article-title":"Acute intraduodenal bile salt depletion leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels in humans.","volume":"12","author":"P Portincasa","year":"2000","journal-title":"Neurogastroenterol Motil."},{"key":"ref-163","doi-asserted-by":"publisher","first-page":"1328-34","DOI":"10.1023\/A:1010635901414","article-title":"Interdigestive gallbladder emptying, antroduodenal motility, and motilin release patterns are altered in cholesterol gallstone patients.","volume":"46","author":"M Stolk","year":"2001","journal-title":"Dig Dis Sci."},{"key":"ref-164","doi-asserted-by":"publisher","first-page":"60-9","DOI":"10.1080\/00855920410011022","article-title":"Relevance of hereditary defects in lipid transport proteins for the pathogenesis of cholesterol gallstone disease.","volume":"39","author":"G Vanberge-Henegouwen","year":"2004","journal-title":"Scand J Gastroenterol Suppl."},{"key":"ref-165","doi-asserted-by":"publisher","first-page":"602-8","DOI":"10.1046\/j.1365-2362.1996.1910532.x","article-title":"Effects of bile salt hydrophobicity on crystallization of cholesterol in model bile.","volume":"26","author":"K Van Erpecum","year":"1996","journal-title":"Eur J Clin Invest."},{"key":"ref-166","doi-asserted-by":"publisher","first-page":"364-75","DOI":"10.1111\/nmo.12734","article-title":"Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.","volume":"28","author":"H Wang","year":"2016","journal-title":"Neurogastroenterol Motil."},{"key":"ref-167","doi-asserted-by":"publisher","first-page":"655-60","DOI":"10.1016\/0270-9139(95)90514-6","article-title":"The natural history of gallstones: the GREPCO experience. The GREPCO Group.","volume":"21","author":"A Attili","year":"1995","journal-title":"Hepatology."},{"key":"ref-168","doi-asserted-by":"publisher","first-page":"949-54","DOI":"10.3109\/00365521.2011.571710","article-title":"A 24-year controlled follow-up of patients with silent gallstones showed no long-term risk of symptoms or adverse events leading to cholecystectomy.","volume":"46","author":"M Schmidt","year":"2011","journal-title":"Scand J Gastroenterol."},{"key":"ref-169","doi-asserted-by":"publisher","first-page":"146-81","DOI":"10.1016\/j.jhep.2016.03.005","article-title":"EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones.","volume":"65","year":"2016","journal-title":"J Hepatol."},{"key":"ref-170","doi-asserted-by":"publisher","first-page":"2368-86","DOI":"10.1007\/s00464-010-1268-7","article-title":"SAGES guidelines for the clinical application of laparoscopic biliary tract surgery.","volume":"24","author":"D Overby","year":"2010","journal-title":"Surg Endosc."},{"key":"ref-171","doi-asserted-by":"publisher","first-page":"629-39","DOI":"10.1097\/00042737-200506000-00007","article-title":"Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones.","volume":"17","author":"T Rabenstein","year":"2005","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"ref-172","doi-asserted-by":"publisher","first-page":"239-43","DOI":"10.1111\/hpb.12356","article-title":"Mortality after a cholecystectomy: A population-based study.","volume":"17","author":"G Sandblom","year":"2015","journal-title":"HPB (Oxford)."},{"key":"ref-173","doi-asserted-by":"publisher","DOI":"10.1016\/j.surge.2018.04.001","article-title":"A systematic review of the aetiology and management of post cholecystectomy syndrome.","author":"J Isherwood","year":"2018","journal-title":"Surgeon."},{"key":"ref-174","doi-asserted-by":"publisher","first-page":"172-87","DOI":"10.5009\/gnl.2012.6.2.172","article-title":"Epidemiology of gallbladder disease: Cholelithiasis and cancer.","volume":"6","author":"L Stinton","year":"2012","journal-title":"Gut Liver."},{"key":"ref-175","doi-asserted-by":"publisher","first-page":"786-794","DOI":"10.1016\/j.hpb.2018.03.004","article-title":"Reporting of complications after laparoscopic cholecystectomy: A systematic review.","volume":"20","author":"H Alexander","year":"2018.","journal-title":"HPB (Oxford)."},{"key":"ref-176","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12939-018-0739-7","article-title":"Effect of socioeconomic inequalities on cholecystectomy outcomes: A 10-year population-based analysis.","volume":"17","author":"P Lu","year":"2018","journal-title":"Int J Equity Health."},{"key":"ref-177","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4614096","article-title":"Evaluation of Early Cholecystectomy versus Delayed Cholecystectomy in the Treatment of Acute Cholecystitis.","volume":"2016","author":"M S\u00e1nchez-Carrasco","year":"2016","journal-title":"HPB Surg."},{"key":"ref-178","doi-asserted-by":"publisher","first-page":"98-107","DOI":"10.1002\/bjs.10317","article-title":"Cost-effectiveness of emergency versus delayed laparoscopic cholecystectomy for acute gallbladder pathology.","volume":"104","author":"A Sutton","year":"2017","journal-title":"Br J Surg."},{"key":"ref-179","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12876-017-0601-1","article-title":"Costs and quality of life of small-incision open cholecystectomy and laparoscopic cholecystectomy - an expertise-based randomised controlled trial.","volume":"17","author":"M Rosenm\u00fcller","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"ref-180","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-018-6295-9","article-title":"Robotic-assisted versus laparoscopic cholecystectomy for benign gallbladder diseases: A systematic review and meta-analysis.","author":"C Han","year":"2018.","journal-title":"Surg Endosc."},{"key":"ref-181","doi-asserted-by":"publisher","first-page":"3-11","DOI":"10.1016\/j.ejim.2018.04.019","article-title":"Cholecystectomy and risk of metabolic syndrome.","volume":"53","author":"A Di Ciaula","year":"2018","journal-title":"Eur J Intern Med."},{"key":"ref-182","doi-asserted-by":"publisher","first-page":"205-13","DOI":"10.4082\/kjfm.2016.37.4.205","article-title":"Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family Physicians.","volume":"37","author":"P Portincasa","year":"2016","journal-title":"Korean J Fam Med."},{"key":"ref-183","doi-asserted-by":"publisher","first-page":"245-64, viii-ix","DOI":"10.1016\/j.gtc.2010.02.005","article-title":"Targets for current pharmacologic therapy in cholesterol gallstone disease.","volume":"39","author":"A Di Ciaula","year":"2010","journal-title":"Gastroenterol Clin North Am."},{"key":"ref-184","doi-asserted-by":"publisher","first-page":"e12958","DOI":"10.1111\/eci.12958","article-title":"Exercising the hepatobiliary-gut axis. The impact of physical activity performance.","volume":"48","author":"E Molina-Molina","year":"2018","journal-title":"Eur J Clin Invest."},{"key":"ref-185","doi-asserted-by":"publisher","first-page":"1448-56","DOI":"10.1038\/ajg.2017.216","article-title":"Diet and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort.","volume":"112","author":"A Barr\u00e9","year":"2017","journal-title":"Am J Gastroenterol."},{"key":"ref-186","doi-asserted-by":"publisher","first-page":"721-6","DOI":"10.1111\/jgh.13531","article-title":"Determinants for clinical events in gallstone carriers unaware of their gallstones.","volume":"32","author":"D Shabanzadeh","year":"2017","journal-title":"J Gastroenterol Hepatol."},{"key":"ref-187","doi-asserted-by":"crossref","first-page":"857-68","DOI":"10.1097\/MCG.0000000000000571","article-title":"Physical Activity and the Risk of Gallstone Disease: A Systematic Review and Meta-analysis.","volume":"51","author":"Y Zhang","year":"2017","journal-title":"J Clin Gastroenterol."},{"key":"ref-188","doi-asserted-by":"publisher","first-page":"20-6","DOI":"10.1016\/j.ypmed.2016.03.016","article-title":"Vegetable protein intake is associated with lower gallbladder disease risk: Findings from the Women's Health Initiative prospective cohort.","volume":"88","author":"E Lander","year":"2016","journal-title":"Prev Med."},{"key":"ref-189","first-page":"39-49","article-title":"Dietary patterns and risk of gallbladder disease: A hospital-based case-control study in adult women.","volume":"33","author":"M Jessri","year":"2015","journal-title":"J Health Popul Nutr."},{"key":"ref-190","doi-asserted-by":"publisher","DOI":"10.3390\/nu9111219","article-title":"Associations between Nut Consumption and Health Vary between Omnivores, Vegetarians, and Vegans.","volume":"9","author":"R Brown","year":"2017","journal-title":"Nutrients."},{"key":"ref-191","doi-asserted-by":"publisher","first-page":"221-7","DOI":"10.1155\/1989\/56539","article-title":"Dietary and other risk factors in the aetiology of cholelithiasis: A case control study.","volume":"1","author":"A Linos","year":"1989","journal-title":"HPB Surg."},{"key":"ref-192","doi-asserted-by":"publisher","first-page":"339-47","DOI":"10.1016\/j.nut.2004.06.028","article-title":"Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.","volume":"21","author":"M Yago","year":"2005","journal-title":"Nutrition."},{"key":"ref-193","doi-asserted-by":"publisher","first-page":"1586-91","DOI":"10.2105\/AJPH.2016.303336","article-title":"Key Findings on Alcohol Consumption and a Variety of Health Outcomes From the Nurses' Health Study.","volume":"106","author":"E Mostofsky","year":"2016","journal-title":"Am J Public Health."},{"key":"ref-194","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12876-017-0674-x","article-title":"Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: Study protocol for a randomized controlled trial (UPGRADE trial).","volume":"17","author":"T Boerlage","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"ref-195","doi-asserted-by":"publisher","first-page":"3021-30","DOI":"10.1007\/s11695-017-2924-y","article-title":"Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: An Updated Systematic Review and Meta-analysis.","volume":"27","author":"D Magouliotis","year":"2017","journal-title":"Obes Surg."},{"key":"ref-196","doi-asserted-by":"publisher","first-page":"681-5","DOI":"10.1016\/j.soard.2016.11.022","article-title":"Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid.","volume":"13","author":"M Coupaye","year":"2017","journal-title":"Surg Obes Relat Dis."},{"key":"ref-197","doi-asserted-by":"publisher","first-page":"844-50","DOI":"10.1007\/s00595-016-1446-x","article-title":"Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.","volume":"47","author":"E Abdallah","year":"2017","journal-title":"Surg Today."},{"key":"ref-198","doi-asserted-by":"publisher","first-page":"990-4","DOI":"10.1007\/s11695-015-1858-5","article-title":"Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.","volume":"26","author":"L Adams","year":"2016","journal-title":"Obes Surg."},{"key":"ref-199","doi-asserted-by":"publisher","first-page":"1090-1100.e2; quiz e61","DOI":"10.1016\/j.cgh.2013.11.031","article-title":"Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials.","volume":"12","author":"C Stokes","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-200","doi-asserted-by":"publisher","first-page":"1808-1834","DOI":"10.1002\/9781118512074.ch89","article-title":"Gallstones.","author":"P Portincasa","year":"2015"},{"key":"ref-201","doi-asserted-by":"publisher","first-page":"421-9","DOI":"10.2174\/1573406413666170209122851","article-title":"Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation.","volume":"13","author":"P Portincasa","year":"2017","journal-title":"Med Chem."},{"key":"ref-202","doi-asserted-by":"publisher","first-page":"1223-7","DOI":"10.1517\/14656566.2012.685161","article-title":"Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease.","volume":"13","author":"A Cariati","year":"2012","journal-title":"Expert Opin Pharmacother."},{"key":"ref-203","doi-asserted-by":"publisher","first-page":"958-66","DOI":"10.1111\/j.1463-1326.2010.01261.x","article-title":"Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events.","volume":"12","author":"M Ahmed","year":"2010","journal-title":"Diabetes Obes Metab."},{"key":"ref-204","doi-asserted-by":"publisher","first-page":"2673-81","DOI":"10.1517\/14656566.2011.629995","article-title":"Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions.","volume":"12","author":"M Ahmed","year":"2011","journal-title":"Expert Opin Pharmacother."},{"key":"ref-205","doi-asserted-by":"publisher","first-page":"366-74","DOI":"10.1016\/j.ejphar.2015.08.045","article-title":"Future therapeutic targets for the treatment and prevention of cholesterol gallstones.","volume":"765","author":"I Castro-Torres","year":"2015","journal-title":"Eur J Pharmacol."},{"key":"ref-206","doi-asserted-by":"publisher","first-page":"158-63","DOI":"10.1177\/1457496913492463","article-title":"Declining cholecystectomy rate during the era of statin use in Finland: a population-based cohort study between 1995 and 2009.","volume":"102","author":"S Suuronen","year":"2013","journal-title":"Scand J Surg."},{"key":"ref-207","doi-asserted-by":"publisher","first-page":"369-74","DOI":"10.1517\/14740338.2012.653560","article-title":"Statin use and the risk of gallstone disease: a population-based case-control study.","volume":"11","author":"H Chiu","year":"2012","journal-title":"Expert Opin Drug Saf."},{"key":"ref-208","doi-asserted-by":"publisher","first-page":"1-9","DOI":"10.1016\/j.ejphar.2017.10.003","article-title":"Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL\/6 mouse model.","volume":"815","author":"M Liu","year":"2017","journal-title":"Eur J Pharmacol."},{"key":"ref-209","doi-asserted-by":"publisher","first-page":"808-18","DOI":"10.1016\/j.ajpath.2016.12.013","article-title":"Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation.","volume":"187","author":"S Cheng","year":"2017","journal-title":"Am J Pathol."},{"key":"ref-210","doi-asserted-by":"publisher","first-page":"1352-8","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.","volume":"10","author":"A Moschetta","year":"2004","journal-title":"Nat Med."},{"key":"ref-211","doi-asserted-by":"publisher","first-page":"218-21","DOI":"10.1002\/hep.20776","article-title":"Is the FXR the fix for cholesterol gallstone disease?","volume":"42","author":"B Juran","year":"2005","journal-title":"Hepatology."},{"key":"ref-212","doi-asserted-by":"publisher","first-page":"2095-106","DOI":"10.1053\/j.gastro.2011.02.055","article-title":"PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts.","volume":"140","author":"J He","year":"2011","journal-title":"Gastroenterology."},{"key":"ref-213","doi-asserted-by":"publisher","first-page":"31-9","DOI":"10.15403\/jgld.2014.1121.271.dll","article-title":"Distinct Effects of two Almond Cultivars on Agreeability and Gastrointestinal Motility in Healthy Subjects: more than mere Nutraceuticals.","volume":"27","author":"G Diella","year":"2018","journal-title":"J Gastrointestin Liver Dis."},{"key":"ref-214","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170619104801","article-title":"Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.","author":"H Wang","year":"2017","journal-title":"Curr Med Chem."},{"key":"ref-215","doi-asserted-by":"publisher","first-page":"G855-64","DOI":"10.1152\/ajpgi.00316.2015","article-title":"Prevention of gallbladder hypomotility via FATP2 inhibition protects from lithogenic diet-induced cholelithiasis.","volume":"310","author":"K Tharp","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"ref-216","doi-asserted-by":"publisher","first-page":"50-6","DOI":"10.3892\/br.2016.672","article-title":"Prevention of gallstones by Lidan Granule: Insight into underlying mechanisms using a guinea pig model.","volume":"5","author":"X Wu","year":"2016","journal-title":"Biomed Rep."},{"key":"ref-217","doi-asserted-by":"publisher","first-page":"677-83","DOI":"10.1016\/j.biopha.2007.12.008","article-title":"EGCG reducing the susceptibility to cholesterol gallstone formation through the regulation of inflammation.","volume":"62","author":"D Shan","year":"2008","journal-title":"Biomed Pharmacother."},{"key":"ref-218","first-page":"551-5; discussion 555\u20136","article-title":"A novel 5-lipoxygenase inhibitor prevents gallstone formation in a lithogenic prairie dog model.","volume":"62","author":"D Kam","year":"1996","journal-title":"Am Surg."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/7-1529\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1529\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1529\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T10:02:48Z","timestamp":1662112968000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/7-1529\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":218,"URL":"https:\/\/doi.org\/10.12688\/f1000research.15505.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.16907.r38498","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.16907.r38499","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/7-1529\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.16907.r38499, Cynthia Ko, Division of Gastroenterology, University of Washington, Washington, USA, 24 Sep 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1529\/v1#referee-response-38499","order":0,"name":"referee-response-38499","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.16907.r38498, Jill Koshiol, Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCIM), Maryland, USA, 24 Sep 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1529\/v1#referee-response-38498","order":1,"name":"referee-response-38498","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}